SLU-PP-332 is a novel small-molecule compound currently being studied for its effects on metabolic activity, mitochondrial function, and endurance pathways. It acts as an agonist of estrogen-related receptors (ERRα/ERRγ), which play a key role in regulating energy expenditure and oxidative metabolism at the cellular level.

Unlike traditional stimulants or metabolic agents, SLU-PP-332 works by mimicking aspects of exercise signaling, promoting increased mitochondrial activity and enhanced substrate utilization. This mechanism has made it a focus of research in areas related to endurance performance, fat metabolism, and metabolic efficiency.

In oral form, SLU-PP-332 provides a convenient route of administration for ongoing research protocols, allowing for consistent systemic exposure without the need for reconstitution or injection-based delivery methods.

Key Features:

• Activates ERRα and ERRγ pathways

• Supports mitochondrial function and oxidative metabolism

• Promotes energy expenditure and substrate utilization

• Non-stimulant mechanism (no direct CNS stimulation)

• Oral format for convenient administration

Applications (Research Context):

• Mitochondrial and metabolic research

• Endurance and exercise-mimetic studies

• Fat metabolism and energy utilization

• Skeletal muscle oxidative capacity research

• Long-duration metabolic studies

Product Notes:

• Store in a cool, dry place

• Keep sealed and protected from moisture

• Intended for research use only